Research Article

Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway

Figure 3

SXSM treatment prevents the reduction in HCN4 expression in the SAN of SSS mice. (a) HCN4/NF160 immunofluorescence staining of heart tissues of mice from the three groups. NF160 (green fluorescence) marks the location of the SAN. DAPI marks the location of the nuclei. (b) Western blot showing the expression of HCN4 in the SAN of mice from the different groups. β-tubulin was a loading control. (c) Quantitative analysis of the western blot results in (b). SHAM: mice underwent sham surgery; SSS: mice underwent Ang II treatment; SXSM: mice underwent Ang II treatment in the presence of SXSM; . SAN, sinoatrial node; SXSM, Shenxian-shengmai oral liquid; SSS, sick sinus syndrome, Ang II, angiotensin II.
(a)
(b)
(c)